Cathelicidin Peptides Inhibit Multiply Antibiotic-Resistant Pathogens from Patients with Cystic Fibrosis

Endogenous peptide antibiotics are under investigation as inhaled therapeutic agents for cystic fibrosis (CF) lung disease. The bactericidal activities of five cathelicidin peptides (LL37 [human], CAP18 [rabbit], mCRAMP [mouse], rCRAMP [rat], and SMAP29 [sheep]), three novel alpha-helical peptides d...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Saiman, Lisa, Tabibi, Setareh, Starner, Timothy D., San Gabriel, Pablo, Winokur, Patricia L., Jia, Hong Peng, McCray, Paul B., Tack, Brian F.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2001
Matèries:	Susceptibility
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90740/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11557478/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.10.2838-2844.2001
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!